BIVI
Income statement / Annual
Last year (2026), BioVie Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2026, BioVie Inc's net income was -$22.07 M.
See BioVie Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2026
|
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
06/30/2026 |
06/30/2025 |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$229.38 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$229.38 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$13.96 M
|
$9.27 M
|
$23.10 M
|
$33.30 M
|
$17.26 M
|
$133.19 M
|
$1.15 M
|
$1.01 M
|
$370.85 K
|
$466.35 K
|
| General & Administrative Expenses |
$8.51 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.26 M
|
$1.77 M
|
$857.88 K
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$8.51 M
|
$8.57 M
|
$0.00
|
$11.55 M
|
$0.00
|
$0.00
|
$0.00
|
$1.26 M
|
$1.77 M
|
$857.88 K
|
| Other Expenses |
$178.34 K
|
$0.00
|
$9.08 M
|
$229.38 K
|
$9.99 M
|
$4.87 M
|
$1.54 M
|
$0.00
|
$0.00
|
$222.93 K
|
| Operating Expenses |
$22.65 M
|
$17.84 M
|
$32.18 M
|
$45.08 M
|
$27.25 M
|
$138.05 M
|
$2.69 M
|
$2.50 M
|
$2.37 M
|
$1.55 M
|
| Cost And Expenses |
$22.65 M
|
$18.07 M
|
$32.18 M
|
$45.08 M
|
$27.25 M
|
$138.05 M
|
$2.69 M
|
$2.50 M
|
$2.37 M
|
$1.55 M
|
| Interest Income |
$596.77 K
|
$853.03 K
|
$1.14 M
|
$562.26 K
|
$44.08 K
|
$21.97 K
|
$0.00
|
$1.16 K
|
$0.00
|
$0.00
|
| Interest Expense |
$17.90 K
|
$332.72 K
|
$2.89 M
|
$4.30 M
|
$2.16 M
|
$559.46 K
|
$4.77 M
|
$273.00
|
$40.96 K
|
$0.00
|
| Depreciation & Amortization |
$178.34 K
|
$229.38 K
|
$229.38 K
|
$229.38 K
|
$229.38 K
|
$230.00 K
|
$229.38 K
|
$229.38 K
|
$229.38 K
|
$229.38 K
|
| EBITDA |
-$21.88 M |
-$16.98 M |
-$29.00 M |
-$45.73 M |
-$23.69 M |
-$129.46 M |
-$2.46 M |
-$2.27 M |
-$2.14 M |
-$1.32 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$578.87 K
|
$524.08 K
|
$59.05 K
|
-$5.18 M
|
$1.17 M
|
$7.81 M
|
-$13.98 M
|
$52.29 K
|
-$40.96 K
|
$222.94 K
|
| Income Before Tax |
-$22.07 M
|
-$17.54 M
|
-$32.12 M
|
-$50.26 M
|
-$26.08 M
|
-$130.25 M
|
-$16.68 M
|
-$2.44 M
|
-$2.41 M
|
-$1.33 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$22.07 M
|
-$17.54 M
|
-$32.12 M
|
-$50.26 M
|
-$26.08 M
|
-$130.25 M
|
-$16.68 M
|
-$2.44 M
|
-$2.41 M
|
-$1.33 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-3.05 |
-12.12 |
-73.05 |
-154.7 |
-106 |
-1482.3 |
-685.2 |
-98.2 |
-317.7 |
-186.1 |
| EPS Diluted |
-3.05 |
-12.12 |
-73.05 |
-154.7 |
-106 |
-1482.3 |
-685.2 |
-98.2 |
-317.7 |
-186.1 |
| Weighted Average Shares Out |
$7.25 M
|
$1.48 M
|
$451.85 K
|
$324.83 K
|
$246.63 K
|
$124.03 K
|
$49.30 K
|
$24.90 K
|
$7.50 K
|
$7.10 K
|
| Weighted Average Shares Out Diluted |
$7.25 M
|
$1.48 M
|
$451.85 K
|
$324.83 K
|
$246.63 K
|
$124.03 K
|
$49.30 K
|
$25.40 K
|
$7.66 K
|
$7.15 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
